GlassScriptPhysician profile
Jacob Burns
NPI 1912432469
$3,808.05
in general payments reported to CMS, 2019-2025
11 companies · $2,986 in 2025
The $2,986 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.24 · 2022: $69.89 · 2023: $199 · 2024: $540 · 2025: $2,986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,599 · Travel and Lodging: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.11 |
| Travel and Lodging | $1,126.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,339.93 | 2025 | Na |
| Abbvie INC. | $1,020.09 | 2023-2025 | |
| Axogen | $464.08 | 2025 | |
| Depuy Synthes Sales INC. | $274.26 | 2024-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Abiomed | $216.65 | 2025 | |
| Medtronic, INC. | $155.69 | 2024 | V-Loc 180 |
| Baxter Healthcare | $119.27 | 2025 | Artiss |
| Polynovo North America LLC | $106.53 | 2024 | Novosorb Btm |
| Davol INC. | $69.89 | 2022 | |
| Medical Device Business Services, INC. | $29.42 | 2025 | Stratafix |
| Allergan, INC. | $12.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.